Current advances in antitubercular drug discovery: potent prototypes and new targets

Nenhuma Miniatura disponível

Data

2015

Orientador

Coorientador

Pós-graduação

Curso de graduação

Título da Revista

ISSN da Revista

Título de Volume

Editor

Bentham Science Publishers

Tipo

Artigo

Direito de acesso

Acesso restrito

Resumo

Tuberculosis (TB) is an infectious disease caused by bacterium of the Mycobacterium genus, mainly by Mycobacterium tuberculosis (MTB). The World Health Organization aims to substantially reduce the number of cases in the coming years; however, the increased number of multidrug-resistant (MDR) and extremely drug-resistant (XDR) forms of the bacterium and the lack of treatment for latent tuberculosis are challenges to be overcome. In this review, we have identified the most potent compounds described in the literature during recent years with MIC values < 7 µM, low toxicity and a high selective index. In addition, emerging targets in MTB are presented to provide new perspectives for the discovery of new antitubercular drugs. This review aims to summarize the current advances in and promote insights into antitubercular drug discovery.

Descrição

Idioma

Inglês

Como citar

Current Medicinal Chemistry, v. 22, n. 27, p. 3133-3161, 2015.

Itens relacionados

Financiadores